- Lobbying
- amgen AND usa
Lobbying Arrangements Results for 'Amgen Usa'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details General trade issues |
Amgen USA, Inc
pharmaceutical company |
THE WALTER GROUP | |||
Details Medicare Coverage and Reimbursement Issues |
AMGEN USA INC.
|
HAMMER ASSOCIATES, LLC | |||
Details Monitor budget discussions surrounding sequestration and fiscal cliff issues and their potential impact on healthcare. |
Amgen USA Inc.
|
Bates Capitol Group, Inc. | |||
Details Healthcare/FDA Clinical Trials. |
Amgen USA Inc.
|
C2 GROUP, LLC | |||
Details Patent policy. |
Amgen USA Inc.
|
ACG Advocacy | |||
Details General health care coverage. Reimbursement for prescription drugs. Medicare Part D issues. |
AMGEN USA INC.
|
TCH Group, LLC | |||
Details Monitor budget discussions surrounding sequestration and fiscal cliff issues and their potential impact on healthcare. |
C2 GROUP (on behalf of Amgen USA Inc.)
|
Bates Capitol Group, Inc. | |||
Details S. Con. Res. 21 - Concurrent Resolution on the Budget for FY 2008 Biologics Price Competition and Innovation Act of 2007 Patent Infringement |
Amgen USA Inc.
|
Downey McGrath Group, Inc. | |||
Details Issues related to End-Stage Renal Disease Prospective Payment System (ESRD PPS) |
Amgen USA
|
CAPITOL SOLUTIONS | |||
Details General health care coverage and reimbursement for prescription drugs; implementation of and reforms to H.R. 3590, the Patient Protection and Affordable Care Act. |
AMGEN USA INC.
|
TCH Group, LLC | |||
Details Medicare Part D reimbursement issues dealing with patient payments in the "doughnut hole." No legislation introduced. Monitor PDUFA (Prescription Drug User Fee Act) reauthorization under S. 3187,... |
Amgen USA Inc.
|
PARRY, ROMANI, DECONCINI & SYMMS | |||
Details Issues related to drug pricing and access, Medicare and Medicaid reimbursement Issues related to pharmaceutical industry, generally; Issues related to drug pricing and access, and Medicare and Medi... |
Horizon Therapeutics USA, Inc.
|
RICCHETTI INCORPORATED | |||
Details Various policies regarding patent reform |
Amgen Inc.
Biotechnology Company |
Michael Solon - Capitol Legistics | |||
Details Tax Reform: International tax provisions as it relates to the taxation of income derived from intangible property. Market based solutions to bring down the cost of drug prices. Centers for Medicare... |
Amgen USA Inc.
|
Advanced Policy Consulting, LLC | |||
Details Monitor tax reform issues, including House GOP Tax Reform Task Force blueprint Monitor legislative discussions on 21st Century Cures (H.R. 6) and Senate biomedical innovation bills; Oppose CMMI pro... |
Amgen USA Inc.
|
Republic Consulting, LLC | |||
Details Issues related to Medicare Part D and Medicare Part B reimbursement and coverage. Issues related to drug pricing. Issues related to Puerto Rico. |
Amgen USA, Inc.
|
OGR (formerly known as Ogilvy Government Relations) | |||
Details Issues related to the implementation of international tax and tax reform (PL 115-97); Issues related to Puerto Rico tax; Issues related to the implementation of the Inflation Reduction Act of 2022 ... |
Amgen USA, Inc.
|
Forbes-Tate | |||
Details General corporate tax issues and pension issues |
UnitedHealth Group
Tax issues related to the Health Care Industry |
Capitol Tax Partners, LLP | |||
Details Monitoring tax legislation. Monitoring healthcare legislation. Education regarding market based solutions to bring down the cost of drug prices. Education regarding the dangers of global counterfei... |
Amgen USA Inc.
|
Advanced Policy Consulting, LLC | |||
Details Medicare Part D; Medicare Part B; S. 1416 - Affordable Prescriptions for Patients Act of 2019; H.R.3 - Lower Drug Costs Now Act of 2019; H.R. 2693 - Increasing Access to Osteoporosis Testing for Me... |
Amgen USA Inc.
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019; issues related to Safe step Act |
Amgen, Inc. FKA Horizon Therapeutics USA, Inc.
|
S-3 Group | |||
Details Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169). Issues related to FDA regulation of pharmaceuticals. Issues related to prescription ... |
Amgen USA Inc.
|
MARSHALL & POPP, LLC | |||
Details Issues related to Pillar 2; Issues related to international tax reform. |
Amgen USA, Inc.
|
AKIN GUMP STRAUSS HAUER & FELD |